Compare

Cero Therapeutics Holdings, Inc. vs Windtree Therapeutics Inc vs Viskase Holdings, Inc. vs Scilex Holding Co

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Cero Therapeutics Holdings, Inc. CERO	Windtree Therapeutics Inc WINTLast annual report: year ended 2024-12-31	Viskase Holdings, Inc. VISKRevenue covers only part of its income (partial revenue)	Scilex Holding Co SCLXRevenue covers only part of its income (partial revenue)
Year ended	2025-12-31	2024-12-31	2025-12-31	2025-12-31
Revenue	n/a	n/a	n/a	$30.25M
Revenue growth (YoY)	n/a	n/a	n/a	-46.5%
Gross margin	n/a	n/a	n/a	65.0% (computed)
Operating margin	n/a	n/a	n/a	n/m
Net margin	n/a	n/a	n/a	n/m
Net income	-$19.92M	-$1.79M	-$3.41M	-$374.05M
EPS (Diluted)	n/a	n/a	-$0.07	-$36.48
Operating cash flow	-$16.10M	-$15.40M	-$3.01M	$3.82M
Free cash flow	n/a	-$15.41M	n/a	$3.68M
Cash & equivalents	n/a	$1.78M	$42.57M	$4.96M
Total assets	$3.64M	$27.88M	$42.81M	$364.98M
Total liabilities	$9.09M	$14.70M	n/a	$576.73M
Shareholders' equity	-$5.45M	$10.00M	-$2.52M	-$207.78M
Return on year-end equity	n/a	-17.9%	n/a	n/a
Shares outstanding	n/a	256.4K	74.21M	7.03M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Cero Therapeutics Holdings, Inc.	Windtree Therapeutics Inc	Viskase Holdings, Inc.	Scilex Holding Co
Latest	n/a	$198.0K Ended 2019-12-31	n/a	n/a
1 year earlier	n/a	$1.79M Ended 2018-12-31	n/a	n/a
2 years earlier	n/a	$1.49M Ended 2017-12-31	n/a	n/a
3 years earlier	n/a	$2.04M Ended 2016-12-31	n/a	n/a
4 years earlier	n/a	$987.0K Ended 2015-12-31	n/a	n/a